| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Target or a Demi-Target
|
Mok, Tony S.
|
|
2010
|
11 |
3 |
p. 147-148
2 p.
|
artikel
|
| 2 |
Carboplatin/Pemetrexed/Bevacizumab in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Single-Institution Experience
|
Malhotra, Binu
|
|
2010
|
11 |
3 |
p. 192-197
6 p.
|
artikel
|
| 3 |
Clinical Risk Factors for Early Complications After High-Dose-Rate Endobronchial Brachytherapy in the Palliative Treatment of Lung Cancer
|
Zaric, Bojan
|
|
2010
|
11 |
3 |
p. 182-186
5 p.
|
artikel
|
| 4 |
Expression of Chemokine Receptor CCR6 as a Molecular Determinant of Adrenal Metastatic Relapse in Patients With Primary Lung Cancer
|
Raynaud, Christophe M.
|
|
2010
|
11 |
3 |
p. 187-191
5 p.
|
artikel
|
| 5 |
Genetic Evolution of Epidermal Growth Factor Receptor in Adenocarcinoma With a Bronchioloalveolar Carcinoma Component
|
Zhong, Wen-Zhao
|
|
2010
|
11 |
3 |
p. 160-168
9 p.
|
artikel
|
| 6 |
Phase II Study of Cetuximab, Docetaxel, and Gemcitabine in Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer
|
Spigel, David R.
|
|
2010
|
11 |
3 |
p. 198-203
6 p.
|
artikel
|
| 7 |
Protein Kinase C-β Gene Variants, Pathway Activation, and Enzastaurin Activity in Lung Cancer
|
Lee, Sang-Haak
|
|
2010
|
11 |
3 |
p. 169-175
7 p.
|
artikel
|
| 8 |
Selected Clinical Trials in Lung Cancer
|
Langer, Corey J.
|
|
2010
|
11 |
3 |
p. 204-205
2 p.
|
artikel
|
| 9 |
The Emerging Role of Biomarkers in Advanced Non–Small-Cell Lung Cancer
|
Socinski, Mark A.
|
|
2010
|
11 |
3 |
p. 149-159
11 p.
|
artikel
|
| 10 |
Whole-Brain Radiation Therapy Plus Concomitant Temozolomide for the Treatment of Brain Metastases From Non–Small-Cell Lung Cancer: A Randomized, Open-Label Phase II Study
|
Chua, Daniel
|
|
2010
|
11 |
3 |
p. 176-181
6 p.
|
artikel
|
Tijdschrift beschrijving